Relapsed - Globe Thesis

Keyword [Relapsed] Result: 181 - 200 \| Page: 10 of 10
181.	Single-Cell Analysis Reveals Biological Characteristics Of Clinical Efficacy In Relapsed Or Refractory Autoimmune Hemolytic Anemia Cohort
182.	Mechanism Of TRF-59:75-Gly-TCC-1-M3-mediated Proliferation And Drug Resistance Regulation In Multiple Myeloma
183.	Investigation Of New Drug Therapeutics For Refractory Or Relapsed B-ALL
184.	The Clinical Efficacy And Influencing Factor Of ASCT Combined With CAR-T Cell Therapy For Relapsed And Refractory Central Nervous System Lymphoma
185.	Clinical And Experimental Study Of Chimeric Antigen Receptor Modified T Cells For Relapsed/Refractory Acute Lymphoblastic Leukemia In Children And Adolescents
186.	Efficacy And Mechanism Research Of Interferon α-1b Combined With Interleukin-2 And Thalidomide In The Treatment Of Acute Myeloid Leukemia
187.	The Clinical And Mechanistic Study Of Synergistic Combination Of IFN-α With CD19/CD22 Bispecific Targeted CAR-T Cell Therapy In Relapsed And Refractory Bcell Acute Lymphoblastic Leukemia
188.	Exploration Of Prognostic Factors In Triple-Negative Breast Cancer With High Risk Of Recurrence And Progression
189.	Study On The Mechanism Of Human-derived CD19 CAR-T Cell Therapy In Rescuing Relapsed/Refractory Diffuse Large B-cell Lymphoma Unresponsive To Mouse-derived CD19 CAR-T Cell Therapy
190.	Preclinical And Single-arm,prospective Clinical Trials Of Fourth-generation CAR-T Cells In Relapsed/refractory Multiple Myeloma And Solid Tumors
191.	Integrated Single-cell Transcriptomics Study Of Refractory/relapsed Childhood Acute B Lymphoblastic Leckemia
192.	B7-H3-targeted CAR-T Cells Against Relapsed Brain Glioblastoma And Medulloblastoma
193.	Study On TCM Syndromes Of CAR-T Therapy For Relapsed/refractory Diffuse Large B-cell Lymphoma And Analysis Of Related Factors Affecting Efficac
194.	Efficacy And Safety Of Targeted BCMA CAR-T Therapy For Relapsed/refractory Multiple Myeloma
195.	Biological And Clinical Study Of Dicitabine Combined With Chemotherapy In The Treatment Of TP53 Mutation Diffuse Large B-cell Lymphoma
196.	A Systematic Review Of The Efficacy And Safety Of Brentuximab Vedotin Combined With Bendamustine In The Treatment Of Relapsed Or Refractory Hodgkin’s Lymphoma
197.	The Efficacy And Safety Of Selinexor In The Treatment Of Relapsed/refractory Multiple Myeloma:meta Analysis
198.	Treatment Effect Of Chidamide In The Conditioning Regimen Of Allogeneic Hematopoietic Stem Cell Transplantation In Relapsed/Refractory Acute Leukemia
199.	Efficacy And Safety Of Venetoclax-based Combinational Therapies In The Treatment Of Relapsed/Refractory Acute Myeloid Leukemia:a Meta-analysis
200.	Retrospective Study Of Bortezomib,Pomalidomide And Dexamethasone(VPd) Regimen In The Treatment Of Relapsed/Refractory Multiple Myeloma
<<First <Prev Next> Last>> Jump to